Close Menu

NEW YORK (GenomeWeb) – LexaGene announced today that it has partnered with Texas A&M Veterinary Medical Diagnostics Laboratory to test canine urine samples on LexaGene's LX6 prototype pathogen detection instrument.

Veterinarians at Texas A&M will send LexaGene clinically annotated urine samples for processing and pathogen detection on the firm's LX6 device. Before sending the samples to LexaGene, Texas A&M will characterize them using current diagnostic technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.